Christopher J. Webster
Research Triangle Park
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher J. Webster.
Headache | 2004
Stewart J. Tepper; Carl Dahlöf; Andrew J. Dowson; Lawrence C. Newman; Hank Mansbach; Martin Jones; Ba Pham; Christopher J. Webster; Reijo Salonen
Context.—Headache experts have suggested that to improve the recognition of migraine, patients with a stable pattern of episodic, disabling headache and a normal physical exam should be considered to have migraine in the absence of contradictory evidence. The premise upon which this approach is based—that is, that episodic, recurrent primary headache in the clinic is usually migraine—has not been evaluated in prospective clinical studies.
Headache | 1997
Arthur Klassen; Arthur Elkind; Mahnaz Asgharnejad; Christopher J. Webster; Antonio Laurenza
Objective.‐To evaluate the efficacy and tolerability of naratriptan, a novel 5‐HT1 agonist, in the acute treatment of migraine.
Headache | 2006
Paul Winner; A. David Rothner; John D. Wooten; Christopher J. Webster; Michael Ames
Objective.—To compare the efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects.
Headache | 2004
Shankar Natarajan; J. T. Jabbour; Christopher J. Webster; Mary S. Richardson
Objective.—This 1‐year, open‐label, multicenter study was designed to assess the long‐term tolerability and efficacy of sumatriptan nasal spray 20 mg in adolescent patients with migraine.
Headache | 2001
P. Burke‐Ramirez; Mahnaz Asgharnejad; Christopher J. Webster; R. Davis; Antonio Laurenza
Objective.—To evaluate efficacy and tolerability of subcutaneous sumatriptan 6 mg versus placebo for acute migraine between ethnic groups.
Headache Care | 2006
Reto Agosti; Carl Dahlöf; Wim M. Mulleners; Martin W. Jones; Christopher J. Webster; Colleen Few
Time to onset of efficacy of the fast-disintegrating/rapid-release formulation of sumatriptan tablets in the acute treatment of migraine Reto Agosti , Carl G. H. Dahlöf , Wim m. mulleners , martin W. Jones , Chris Webster e and Colleen Few e Headache Center Hirslanden Zürich, Zürich, Switzerland Gothenburg Migraine Clinic, Gothenburg, Sweden Department of Neurology, Atrium Medical Center, Heerlen, The Netherlands GlaxoSmithKline, Greenford, United Kingdom GlaxoSmithKline, Research Triangle Park, North Carolina, United States
JAMA Internal Medicine | 2004
Curtis P. Schreiber; Susan Hutchinson; Christopher J. Webster; Michael Ames; Mary S. Richardson; Connie Powers
Clinical Therapeutics | 2007
Gary Ishkanian; Harvey Blumenthal; Christopher J. Webster; Mary S. Richardson; Michael Ames
Clinical Therapeutics | 2006
Jeanette Wendt; Roger K. Cady; Richard Singer; Kenneth Peters; Christopher J. Webster; Shashidhar Kori; Susan Byrd
JAMA Internal Medicine | 2005
Curtis P. Schreiber; Christopher J. Webster
